Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cedars-Sinai researchers detail events that enable brain tumors to weaken immune system

25.07.2003


In an article appearing in a special issue of the Journal of Neuro-oncology, researchers at Cedars-Sinai Medical Center’s Maxine Dunitz Neurosurgical Institute describe a complex cell-level process that allows malignant brain tumors to protect themselves by damaging the thymus, rapidly degrading the immune system. In a second article, Institute scientists identify a molecular mechanism that causes cell death of cancer-fighting lymphocytes as they infiltrate a brain tumor.



"We are dissecting and better understanding the mechanisms that enable tumors to evade destruction by the immune system. This gives us new tools in our fight against brain cancer, to essentially correct these deficits and further enhance the ability of the immune system, not only to detect but also to destroy brain tumors," said Keith L. Black, M.D., director of the Institute, Cedars-Sinai’s Division of Neurosurgery and the Comprehensive Brain Tumor Program.

In an animal study, researchers found that intracranial gliomas – aggressive brain tumors – damage the thymus, the gland responsible for the development and potency of the immune system’s T cells. As the thymus shrinks and its normal structure becomes distorted, many of the thymocytes – the "immature" cells destined to become functional T cells potentially capable of destroying a variety of antigens – undergo a process that weakens and kills them.


Thymocytes are derived from bone marrow and as they travel through the thymus they go through a natural selection process that removes the weakest and prepares the strongest to become lymphocytes that can later adapt as needed to meet a variety of immune challenges. When an intracranial glioma is present, the researchers found, the number of healthy T cells leaving the thymus is dramatically reduced, preventing a large-scale attack on the tumor.

Changes to the thymus and "recent thymic emigrant" (RTE) T cells are similar to those seen in advanced cases of AIDS, in which HIV causes thymocyte death. In glioma progression, researchers believe glucocorticoids, hormones produced by the adrenal glands, are involved in the loss of thymocytes.

The authors noted that physical stress on the body may play a significant role because it causes the release of glucocorticoids. In rats that had their adrenal glands removed to reduce the production of glucocorticoids, the damaging effects were significantly less pronounced.

This finding may also have implications for the way physicians currently treat swelling of brain tissue in patients who have brain tumors. Synthetic glucocorticoids administered to reduce intracranial pressure are highly effective for this purpose but their impact on the thymus and T cells may be further inhibiting an already embattled immune system.

Although CD8(+) cells are produced elsewhere in the body, those originating in the thymus appear to have special relevance in anti-glioma immunity, according to the study.

"It appears that these recent thymic emigrant T cells preferentially home to gliomas or they have an enhanced anti-tumor activity that allows them to home there preferentially," said Christopher J. Wheeler, Ph.D., research scientist and corresponding author on both papers.

"In a sense, we see two mechanisms working against each other," said Dr. Wheeler, "Recent thymic emigrant T cells are homing to the tumor, but there is a subversion of thymic function by the tumor itself. Therefore, while we have those cells preferentially homing – they’re enriched relative to other cells – we don’t have a lot of those cells to begin with."

According to the second paper, the tumor’s immediate environment also changes in a way that thwarts an effective tumor-infiltrating response.

The population of "types" of T cells found in aggressive, malignant tumors was out of balance compared to the response seen in benign tumors. Benign tumors had a high proportion of CD8(+) T cells compared to CD4(+) T cells, which is an indication of a strong tumor-killing immune response. In contrast, nearly all gliomas exhibited greater proportions of CD4(+) relative to CD8(+) T cells.

This manipulation of tumor-infiltrating lymphocytes does not appear to be controlled by the tumor cells themselves but at least to some extent by properties of surrounding tissue, and the ratio correlated directly with the involvement of specific protein molecules detected in nearby cells.

The suspect proteins, Fas ligand (FasL) and Fas, exist in normal brain and blood vessel lining tissue and play a role in immune system regulation. Based on this study, however, they also are expressed on tumor-associated endothelial cells where they may intercept the cancer-fighting T lymphocytes. Endothelial cells make up the lining of blood vessels.

According to the article, increasing levels of endothelial FasL correlated with decreasing proportions of tumor-infiltrating cytotoxic T lymphocytes – tumor-killing immune cells. This suggests the possibility that Fas ligand contributes to a tumor’s ability to evade the immune system.

Taken together, the studies indicate that malignant brain tumors are protected against immunity because the number of potential T cells is reduced in the thymus, and those that initially survive may later be damaged or destroyed.

Malignant gliomas continue to be considered incurable with a short length of survival, although researchers at the Institute have devised a vaccine strategy that has provided encouraging results in early trials. The treatment, called dendritic cell immunotherapy, assists the immune system in recognizing cancer cells as targets for attack, but it depends on the existence of healthy T cells to launch and sustain the immune response.

"The immune system will try to fight off a malignant brain tumor but because it does not accomplish this very effectively, we’re trying to enhance its ability with our cancer vaccine and other therapies," said Dr. Black, who holds Cedars-Sinai’s Ruth and Lawrence Harvey Chair in Neuroscience.

"We know that the strongest predictor of survival in patients with brain tumors is age. The younger immune system is better able to put up resistance than an older immune system because the thymus naturally becomes weaker and it has fewer precursors of immune cells to recruit in the fight against the tumor. We observe a strong correlation between the survival of a tumor and patient age, which is directly proportional to the number of T cells produced by the thymus."

The current studies provide insights that may lead to methods to prevent loss of T cells, repair those that become damaged, and strengthen and replenish the supply needed to contain and destroy brain tumors.

Sandra Van | EurekAlert!
Further information:
http://www.csmc.edu

More articles from Health and Medicine:

nachricht Inselspital: Fewer CT scans needed after cerebral bleeding
20.03.2019 | Universitätsspital Bern

nachricht Building blocks for new medications: the University of Graz is seeking a technology partner
19.03.2019 | Karl-Franzens-Universität Graz

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The taming of the light screw

DESY and MPSD scientists create high-order harmonics from solids with controlled polarization states, taking advantage of both crystal symmetry and attosecond electronic dynamics. The newly demonstrated technique might find intriguing applications in petahertz electronics and for spectroscopic studies of novel quantum materials.

The nonlinear process of high-order harmonic generation (HHG) in gases is one of the cornerstones of attosecond science (an attosecond is a billionth of a...

Im Focus: Magnetic micro-boats

Nano- and microtechnology are promising candidates not only for medical applications such as drug delivery but also for the creation of little robots or flexible integrated sensors. Scientists from the Max Planck Institute for Polymer Research (MPI-P) have created magnetic microparticles, with a newly developed method, that could pave the way for building micro-motors or guiding drugs in the human body to a target, like a tumor. The preparation of such structures as well as their remote-control can be regulated using magnetic fields and therefore can find application in an array of domains.

The magnetic properties of a material control how this material responds to the presence of a magnetic field. Iron oxide is the main component of rust but also...

Im Focus: Self-healing coating made of corn starch makes small scratches disappear through heat

Due to the special arrangement of its molecules, a new coating made of corn starch is able to repair small scratches by itself through heat: The cross-linking via ring-shaped molecules makes the material mobile, so that it compensates for the scratches and these disappear again.

Superficial micro-scratches on the car body or on other high-gloss surfaces are harmless, but annoying. Especially in the luxury segment such surfaces are...

Im Focus: Stellar cartography

The Potsdam Echelle Polarimetric and Spectroscopic Instrument (PEPSI) at the Large Binocular Telescope (LBT) in Arizona released its first image of the surface magnetic field of another star. In a paper in the European journal Astronomy & Astrophysics, the PEPSI team presents a Zeeman- Doppler-Image of the surface of the magnetically active star II Pegasi.

A special technique allows astronomers to resolve the surfaces of faraway stars. Those are otherwise only seen as point sources, even in the largest telescopes...

Im Focus: Heading towards a tsunami of light

Researchers at Chalmers University of Technology and the University of Gothenburg, Sweden, have proposed a way to create a completely new source of radiation. Ultra-intense light pulses consist of the motion of a single wave and can be described as a tsunami of light. The strong wave can be used to study interactions between matter and light in a unique way. Their research is now published in the scientific journal Physical Review Letters.

"This source of radiation lets us look at reality through a new angle - it is like twisting a mirror and discovering something completely different," says...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

International Modelica Conference with 330 visitors from 21 countries at OTH Regensburg

11.03.2019 | Event News

Selection Completed: 580 Young Scientists from 88 Countries at the Lindau Nobel Laureate Meeting

01.03.2019 | Event News

LightMAT 2019 – 3rd International Conference on Light Materials – Science and Technology

28.02.2019 | Event News

 
Latest News

Solving the efficiency of Gram-negative bacteria

22.03.2019 | Life Sciences

Bacteria bide their time when antibiotics attack

22.03.2019 | Life Sciences

Open source software helps researchers extract key insights from huge sensor datasets

22.03.2019 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>